Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.515 USD | +7.94% | 0.00% | -39.90% |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
04-25 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.90% | 522M | |
+1.52% | 42.75B | |
+47.70% | 41.61B | |
+12.01% | 41.34B | |
-8.83% | 26.59B | |
+6.99% | 25.49B | |
-23.27% | 18.12B | |
+30.13% | 12.24B | |
-2.50% | 11.76B | |
+8.29% | 11B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CUREVAC : Berenberg reaffirms its Buy rating